Manoj Jadhav, MPharm, PhD, FCP

Courtesy Faculty
(352) 507-9092
Curriculum Vitae

Dr. Jadhav, is a trained clinical pharmacologist with 10+ years of international research experience in pharmaceutical and clinical drug development. Dr. Jadhav has expertise spanning the areas like formulation development, preclinical and clinical research. He has a strong command and thorough understanding of the ICH-GCP, GLP guidelines per local and international regulatory requirements. Dr. Jadhav has worked in the area of cardiovascular diseases (hypertension, intervention cardiology, epidemiology), infectious diseases (HIV/AIDS, dengue fever), cancer (AML, ALL), and Quality of Life studies in arthritis. He has extensively worked on planning, designing, conducting and analysis of several clinical studies (single, multicenter, BA/BE, Phase II, III, IV, PK study etc.) sponsored by the government, industry and in academic settings internationally.

Dr. Jadhav has authored over 30 publications, including peer reviewed original research manuscripts and book chapter. He also co-edited a multi-authored textbook entitled “Emerging Trends in Phytopharmaceuticals” He serves as a reviewer to several research journals e.g. Journal of Clinical Pharmacology, Clinical Pharmacology and Drug Development, Drug Development and Industrial Pharmacy etc. Dr. Jadhav, has excellent record of preparation and submission of research grants, manuscript writing and research publications. He is founder member of South Asian Chapter of American College of Clinical Pharmacology (SAC-ACCP), Fellow of ACCP; and member of AMWA.

Before flying to the USA, he had worked as an assistant professor, at Department of Infectious Diseases, Maharashtra University of Health Sciences, Seth G.S. Medical College and KEM Hospital, Parel, Mumbai and had a brief stint at Fortis Clinical Research Ltd., India.

Dr. Jadhav, spent over four years pursuing his post-doctoral studies at the University of Florida, Gainesville FL. He completed his PhD from University of Mumbai, India. He is firm believer of need to fostering “Translational Medicine” in the drug development and clinical pharmacology.